Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ExonHit looks for US inroads with new HQ (headquarters):

This article was originally published in Clinica

Executive Summary

ExonHit Therapeutics, the Paris, France company known for its proprietary gene profiling DATAS (differential analysis of transcript with alternative splicing) technology to develop pharmaceuticals and diagnostics, has opened a regional US headquarters office in Gaithersburg, Maryland. The US foothold will be used as a platform to develop alliances across its range of products and businesses, including blood based diagnostics. The company already has pharma-based agreements with Allergan and IDEC. The US operation will be under the overall control of ExonHit CEO Bruno Tocque, while Christina Hedberg will head up business development from the US office.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066318

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel